Skip to content
StockMarketAgent
Direct answer
EMR trades against a final fair-value range of $88.69-$155.92, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs. Fair value range: low $88.7, high $156, with mid-point at $122.
Stock analysis

EMR fair value $89–$156

By StockMarketAgent.AI team· supervised by
已分析: 2026-05-13下次更新: 2026-08-13Methodology v2.5Review: automatedArchetype: Mature compounder
View archive
股价
$137.28
▼ -15.07 (-10.98%)
公允价值
$122
$89–$156
评级
减持
confidence 87/100
上行空间
-11.0%
upside to fair value
安全边际
$103.88
MoS level · 15%
市值
$76.9B
P/E fwd 19.2
英文原文ZH
翻译期间显示英文原文
此报告尚未翻译。翻译队列赶上后请在几分钟内刷新。

§1 执行摘要

  • Composite fair value $122 with high case $156.
  • Implied downside of 11.0% to fair value.
  • Moat 9/10 · confidence 87/100 · Mature compounder.
  • Currently screens above fair value, so patience matters more than entry speed.
Fair value
$122
Margin of safety
-12.3%
Confidence
87/100
Moat
9/10

Educational analysis only — not financial advice. Always do your own due diligence.

$137.28Price
Low $88.69
Mid $122.21
High $155.92

EMR trades against a final fair-value range of $88.69-$155.92, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.

  • High switching costs associated with
    High switching costs associated with mission-critical process automation platforms like DeltaV.
  • Sticky, high-margin software and service
    Sticky, high-margin software and service recurring revenue base.
  • Bull thesis
    Reduce-side internal valuation cross-checks ($164.87) aggressively prices in perfect execution of the M&A synergy playbook and permanent retention of 24.2% outlier margins.

§2 看空情景

A synchronized global industrial recession combined with delays in clean energy CAPEXCapital expendituresCash spent on acquiring or upgrading property, plant, and equipment. Splits into maintenance capex (sustaining current capacity) and growth capex (expanding capacity). stalls near-term automation spending. The newly acquired software segments fail to offset hardware cyclicality, causing margins to revert to the 16% historical peer average.

该论点可能失败的方式

M&A Value Destruction

20%· Medium

Failure to extract synergies from recent software acquisitions causes ROIC to stagnate below WACC, driven by the $18B goodwill burden.

FV impact
$88.69 (Implies ~35% downside)

Automation CAPEX Freeze

25%· Medium

Macroeconomic weakness and deferred conventional energy projects significantly halt process automation spending across key markets.

FV impact
Significant multiple compression to 15x legacy industrial norms.

Margin Reversion

30%· Medium

Current 24.2% operating margins prove unsustainable and revert to the 16% historical industry norm amidst competitive pricing pressures.

FV impact
Downside to the Multi-Stage Moat Fade midpoint of $77.53.
需关注的早期预警信号
指标当前触发阈值
Consecutive quarters of declining software and services recurring revenue.MonitorDeterioration versus the report thesis
Operating margins compressing below the 21% normalized assumption.MonitorDeterioration versus the report thesis
Unadjusted ROIC falling further below current 6.9% due to asset bloat.MonitorDeterioration versus the report thesis
Significant downward revisions in forward private EPS estimate reference.MonitorDeterioration versus the report thesis
Management pausing or cutting the dividend/buyback program to preserve cash.MonitorDeterioration versus the report thesis

§3 财务历史

损益表 — 最近六期
项目T−0T−1T−2T−3CAGR
期间2022-09-302023-09-302024-09-302025-09-30Trend
营业收入$13.80B$15.17B$17.49B$18.02B+9.3%
毛利$6.31B$7.43B$8.89B$9.52B+14.7%
营业利润$2.36B$2.76B$2.67B$3.53B+14.4%
净利润$3.23B$13.22B$1.97B$2.29B-10.8%
每股收益(摊薄)$5.41$22.88$3.43$4.04-9.3%
EBITDA$3.50B$4.22B$4.03B$4.84B+11.4%
研发
销售管理费用$3.61B$4.19B$5.14B$5.10B+12.2%

质量评分

OCF / 净利润
1.35×
>1 表示盈利质量高
会计质量门槛
Fail
经行业调整门槛
ROIC
7.7%
投入资本回报率
第 3 节

Numbers analysis

现金流

Cash-flow quality is reflected in the OCFOperating cash flowCash generated from the company's core operations after working-capital changes but before capital expenditures. The first line of the cash-flow statement. / net incomeNet IncomeNet Income is an income-statement line item used to reconcile revenue to operating profit, pre-tax income, net income, or per-share earnings. It should be compared across periods and against peer disclosure conventions., accounting-quality, and ROICROICReturn on invested capital. Operating profit (after tax) divided by invested capital. The single best gauge of capital-efficiency. Spread over WACC = economic value created. rows above.

资本配置

Capital allocation should be evaluated against reinvestment needs, balance-sheet strength, and shareholder returns.

个人订阅用户 — §4 及之后还有 11 个章节

阅读完整分析 — 还有 11 个章节。

Competitive moat, industry cycle, peer comparison, intrinsic valuation, sensitivity, scenarios, earnings decision tree, position management, investor perspectives, scorecard, and final recommendation.

涵盖每个股票的完整报告
24 个月的评级存档
关注列表简报 + 评级变更提醒
以任意语言导出 PDF + DOCX
开始免费试用
可随时取消。
FAQ

EMR — frequently asked questions

  1. Based on our latest analysis, EMR screens modestly overvalued. The current price is $137 versus a composite fair-value midpoint of $122 (range $88.7–$156), which implies roughly 11.0% downside to the midpoint.
Related coverage

Names readers of EMR also follow

Same archetype: mature-compounder